Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Q&A: The Alzheimer's Disease Neuroimaging Initiative.

Aisen PS.

BMC Med. 2011 Sep 1;9:101. doi: 10.1186/1741-7015-9-101. No abstract available.

PMID:
21884605
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Maximizing the Alzheimer's Disease Neuroimaging Initiative II.

Carrillo MC, Sanders CA, Katz RG.

Alzheimers Dement. 2009 May;5(3):271-5. doi: 10.1016/j.jalz.2009.02.005. Epub 2009 Apr 11.

PMID:
19362888
[PubMed - indexed for MEDLINE]
3.

New lessons from the Alzheimer's Disease Neuroimaging Initiative.

Salloway S.

Arch Neurol. 2011 Jan;68(1):19-21. doi: 10.1001/archneurol.2010.344. No abstract available.

PMID:
21220673
[PubMed - indexed for MEDLINE]
4.

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease.

Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, Rogers J, Siemers E, Trojanowski JQ; National Institute on Aging Biological Markers Working Group.

Neurobiol Aging. 2003 Jul-Aug;24(4):521-36. Review. No abstract available.

PMID:
12714109
[PubMed - indexed for MEDLINE]
5.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
[PubMed - indexed for MEDLINE]
6.

[Alzheimer's disease Neuroimaging Initiative (ADNI)].

Iwatsubo T.

Nihon Rinsho. 2011 Oct;69 Suppl 8:570-4. Japanese. No abstract available.

PMID:
22787853
[PubMed - indexed for MEDLINE]
7.

Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).

Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, Geroldi C, Binetti G, Johannsen P, Rossini PM, Wahlund LO, Vellas B, Blennow K, Hampel H.

Exp Gerontol. 2009 Sep;44(9):579-85. doi: 10.1016/j.exger.2009.06.003. Epub 2009 Jun 16.

PMID:
19539742
[PubMed - indexed for MEDLINE]
8.

Predictive biomarkers for Alzheimer's disease using state-of-the-art brain imaging techniques.

Mandal PK.

J Alzheimers Dis. 2012;31 Suppl 3:S1-3. No abstract available.

PMID:
22903126
[PubMed - indexed for MEDLINE]
9.

Alzheimer's Disease Neuroimaging Initiative special issue.

Frisoni GB, Weiner MW.

Neurobiol Aging. 2010 Aug;31(8):1259-62. doi: 10.1016/j.neurobiolaging.2010.05.006. Epub 2010 Jun 8. No abstract available.

PMID:
20570400
[PubMed - indexed for MEDLINE]
10.

Advanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference.

Mungas D, Crane PK, Gibbons LE, Manly JJ, Glymour MM, Jones RN.

Brain Imaging Behav. 2012 Dec;6(4):485-8. doi: 10.1007/s11682-012-9211-2.

PMID:
23232798
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The Alzheimer's disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board.

Schmidt ME, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H.

Alzheimers Dement. 2010 May;6(3):286-90. doi: 10.1016/j.jalz.2010.03.010.

PMID:
20451878
[PubMed - indexed for MEDLINE]
12.

[Alzheimer's Disease Cooperative Study (ADCS)].

Mori H, Ikeuchi T.

Brain Nerve. 2014 Jun;66(6):691-8. Review. Japanese.

PMID:
24899351
[PubMed - indexed for MEDLINE]
13.

Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.

Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D; AIBL research group.

Alzheimers Dement. 2010 May;6(3):291-6. doi: 10.1016/j.jalz.2010.03.009.

PMID:
20451879
[PubMed - indexed for MEDLINE]
14.

Perspective on the Alzheimer's disease neuroimaging initiative: progress report and future plans.

Khachaturian ZS.

Alzheimers Dement. 2010 May;6(3):199-201. doi: 10.1016/j.jalz.2010.04.002. No abstract available.

PMID:
20451867
[PubMed - indexed for MEDLINE]
15.

Perspective: in search of biomarkers.

Buckholtz NS.

Nature. 2011 Jul 13;475(7355):S8. doi: 10.1038/475S8a. No abstract available.

PMID:
21760582
[PubMed - indexed for MEDLINE]
16.

Biomarkers: warning signs.

Williams R.

Nature. 2011 Jul 13;475(7355):S5-7. doi: 10.1038/475S5a. No abstract available.

PMID:
21760581
[PubMed - indexed for MEDLINE]
17.

The predisposing factors, biological markers, neuroimaging techniques and medical complications associated with Alzheimer's disease.

Hasan MK, Mooney RP.

W V Med J. 2011 May-Jun;107(3):26-9. Review.

PMID:
21702411
[PubMed - indexed for MEDLINE]
18.

Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future.

Iwatsubo T.

Alzheimers Dement. 2010 May;6(3):297-9. doi: 10.1016/j.jalz.2010.03.011.

PMID:
20451880
[PubMed - indexed for MEDLINE]
19.

Problems associated with biological markers of Alzheimer's disease.

Frey HJ, Mattila KM, Korolainen MA, Pirttilä T.

Neurochem Res. 2005 Dec;30(12):1501-10.

PMID:
16362769
[PubMed - indexed for MEDLINE]
20.

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.

Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL.

Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165.

PMID:
19763117
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk